Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 14/20 | 1.00 |
| ▸ | KDM6B | O15054 | 7/20 | 1.00 |
| ▸ | KDM4D | Q6B0I6 | 4/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | KDM4A | O75164 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | THRB | P10828 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 1.00 |
| ▸ | GLA | P06280 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29270366 | 1.00 | KDM4C (1.00) | KDM4CKDM6BKDM4DKDM4EALDH1A1 | |
| SCHEMBL535569 | 1.00 | KDM4C (1.00) | KDM4CKDM6BKDM4DKDM4EALDH1A1 | |
| Bromide SCHEMBL5768959 | 0.98 | KDM4C (0.96) | KDM4CKDM6BKDM4DKDM4EALDH1A1 | |
| Nitrous Acid SCHEMBL29105410 | 0.92 | KDM4C (0.85) | KDM4CKDM6BKDM4DKDM4EALDH1A1 | |
| Pyridine SCHEMBL29170612 | 0.91 | KDM4C (0.82) | KDM4CKDM6BKDM4DKDM4EALDH1A1 | |
| SCHEMBL1643711 | 0.84 | KDM4C (0.73) | KDM4CKDM6BKDM4DKDM4EALDH1A1 | |
| SCHEMBL244632 | 0.83 | KDM4C (0.70) | KDM4CKDM6BKDM4DKDM4EALDH1A1 | |
| SCHEMBL220890 | 0.83 | KDM4C (0.70) | KDM4CKDM6BKDM4DKDM4EALDH1A1 | |
| SCHEMBL2139056 | 0.83 | KDM4E (0.70) | KDM4CKDM6BKDM4DKDM4EALDH1A1 | |
| SCHEMBL30785801 | 0.83 | KDM4C (0.70) | KDM4CKDM6BKDM4DKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120137651-A | Perovskite quantum dot and perovskite photovoltaic module | 江苏东鋆光伏科技有限公司 | 2025-06-13 | — | — | CN | claimed |
| US-12151046-B2 | Composite antibacterial hydrogel dressing, preparation method and application thereof | GUANGDONG OCEAN UNIVERSITY (CN) | 2024-11-26 | — | — | US | claimed |
| US-20240277894-A1 | COMPOSITE ANTIBACTERIAL HYDROGEL DRESSING, PREPARATION METHOD AND APPLICATION THEREOF | GUANGDONG OCEAN UNIVERSITY (CN) | 2024-08-22 | — | — | US | claimed |
| CN-118325106-A | Cd-MOF material based on aminoisonicotinic acid, preparation method and application | 中原工学院 | 2024-07-12 | — | — | CN | claimed |
| WO-2024139662-A1 | COMPOSITE ANTIBACTERIAL HYDROGEL DRESSING, PREPARATION METHOD THEREFOR, AND USE THEREOF | 广东海洋大学 | 2024-07-04 | — | — | WO | claimed |
| CN-116099035-B | Composite antibacterial hydrogel dressing and preparation method and application thereof | 广东海洋大学 | 2023-09-08 | — | — | CN | claimed |
| CN-116099035-A | Composite antibacterial hydrogel dressing and preparation method and application thereof | 广东海洋大学 | 2023-05-12 | — | — | CN | claimed |
| WO-2023065541-A1 | COMPOSITE MATERIAL WITH RAPID BLOOD COAGULATION EFFECT AND PREPARATION METHOD THEREFOR | 广东海洋大学 | 2023-04-27 | — | — | WO | claimed |
| CN-113769150-B | Composite material with rapid blood coagulation effect and preparation method thereof | 广东海洋大学 | 2022-05-17 | — | — | CN | claimed |
| US-20260145159-A1 | MIXED MODE CHARGE INDUCTION ION EXCHANGE (IEX) CHROMATOGRAPHY (MMCIIC) LIGANDS AND METHODS OF USE | BIO-RAD LABORATORIES, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| WO-2025081045-A9 | CYSTEINE COVALENT MODIFIERS OF AKT1 AND USES THEREOF | TERREMOTO BIOSCIENCES, INC. (US) | 2025-12-26 | — | — | WO | disclosed |
| CN-120137651-A | Perovskite quantum dot and perovskite photovoltaic module | 江苏东鋆光伏科技有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-120137651-A | Perovskite quantum dot and perovskite photovoltaic module | 江苏东鋆光伏科技有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-114621222-B | 6-6 Fused bicyclic heteroaryl compounds and their use as LATS inhibitors | 诺华股份有限公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-115667504-A | Methods and compositions for ocular cell therapy | 诺华股份有限公司 | 2023-01-31 | — | — | CN | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-11458138-B2 | 6-6 fused bicyclic heteroaryl compounds and their use as LATS inhibitors | NOVARTIS AG (CH) | 2022-10-04 | — | — | US | disclosed |
| CN-114703144-A | 6-6 fused bicyclic heteroaryl compounds and their use as LATS inhibitors | 诺华股份有限公司 | 2022-07-05 | — | — | CN | disclosed |
| CN-114621222-A | 6-6 fused bicyclic heteroaryl compounds and their use as LATS inhibitors | 诺华股份有限公司 | 2022-06-14 | — | — | CN | disclosed |
| CN-113769150-B | Composite material with rapid blood coagulation effect and preparation method thereof | 广东海洋大学 | 2022-05-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11458138-B2 | 6-6 fused bicyclic heteroaryl compounds and their use as LATS inhibitors | LATS1, LATS2, LSS | KDM4C 3907/4885KDM6B 2434/4885KDM4D 3748/4885 |
| US-20260145159-A1 | MIXED MODE CHARGE INDUCTION ION EXCHANGE (IEX) CHROMATOGRAPHY (MMCIIC) LIGANDS AND METHODS OF USE | MLX, MIF, TIMCC | KDM4C 1724/4885KDM6B 3341/4885KDM4D 3117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.